Using BPC-157 may address both gut and skin aspects of psoriasis simultaneously
It is used as a potent, IGFBP-resistant supplement to support cell growth, survival, and productivity in serum-free and serum-reduced media, including in bioprocessing and stem-cell applications
What This Trend Means for Clinical Practice Patients are no longer coming to visits relying solely on subjective symptoms or self-reported food intake
Key Takeaways On April 1, 2026, FDA issued a statement reminding 503A pharmacies and 503B outsourcing facilities that compounded drugs qualify for the statutory exemptions under the Federal Food, Drug, and Cosmetic Act (FD&C Act), only when applicable conditions are satisfied, with specific focus on the essentially a copy standard
They identified 31,774 reports that involved semaglutide-based drugs